Endovascular Salvage of Thrombosed AVF/AVG: A Comprehensive Clinical Guide

The maintenance of vascular access is the cornerstone of successful long-term hemodialysis. For patients with End-Stage Renal Disease (ESRD), the creation and preservation of an Arteriovenous Fistula (AVF) or Arteriovenous Graft (AVG) are paramount. Thrombosis—the acute clotting of these conduits—remains the leading cause of access failure. Endovascular salvage, or "declotting," serves as the gold-standard intervention to restore patency, prolong access survival, and avoid the morbidity associated with surgical revision or the placement of temporary dialysis catheters.

1. Introduction and Overview

Vascular access thrombosis presents as an acute medical emergency for the hemodialysis patient. When an AVF or AVG clots, the patient is unable to receive life-sustaining dialysis, necessitating immediate intervention. Endovascular salvage utilizes minimally invasive, image-guided techniques to remove the thrombus (thrombectomy) and address the underlying anatomical lesion (angioplasty) that precipitated the clotting. This approach is preferred over surgical thrombectomy due to lower perioperative morbidity, faster recovery times, and the ability to perform the procedure under local anesthesia.

2. Technical Specifications and Mechanisms of Action

Endovascular salvage is not merely the removal of a clot; it is a systematic approach to restoring hemodynamic flow.

Core Mechanisms

• Mechanical Thrombectomy: Utilization of specialized devices such as the AngioJet (rheolytic thrombectomy), Arrow-Trerotola (percutaneous mechanical thrombectomy), or aspiration catheters to physically disrupt and remove fibrin and platelet-rich clots.
• Pharmacomechanical Thrombolysis: The delivery of thrombolytic agents (e.g., tissue plasminogen activator - tPA) directly into the clot, often combined with mechanical disruption to expedite clot dissolution.
• Percutaneous Transluminal Angioplasty (PTA): Post-thrombectomy, the underlying stenosis (usually venous outflow stenosis) is dilated using high-pressure balloons to prevent rapid re-thrombosis.

Required Instrumentation

3. Clinical Indications and Usage

The decision to pursue endovascular salvage is based on clinical presentation and imaging confirmation.

Clinical Indications

• Sudden Loss of Thrill/Bruit: Physical examination finding indicating acute occlusion.
• Inability to Cannulate: Failure to achieve blood flow during scheduled dialysis sessions.
• Elevated Venous Pressures: Persistent high pressures during dialysis, suggesting a stenotic lesion that has progressed to total thrombosis.
• Imaging Confirmation: Ultrasound or formal angiographic evidence of thrombus within the graft or fistula body.

Patient Pre-Op Preparation

1. Laboratory Assessment: CBC (platelet count), coagulation profile (PT/INR/PTT), and basic metabolic panel.
2. Anticoagulation Management: Hold therapeutic anticoagulation if possible; however, systemic heparinization is typically administered during the procedure.
3. Informed Consent: Detailed discussion regarding the risk of embolization, vessel rupture, and the potential need for surgical intervention if endovascular techniques fail.
4. Prophylactic Antibiotics: Administration of broad-spectrum antibiotics (e.g., Vancomycin or Cefazolin) is standard practice to prevent bacteremia.

4. The Procedure: A Step-by-Step Clinical Workflow

Step 1: Access and Sheath Placement

Under ultrasound guidance, the graft or fistula is accessed percutaneously. Antegrade and retrograde sheaths are placed to allow access to both the arterial and venous limbs of the circuit.

Step 2: Diagnostic Angiography

Contrast is injected to map the entire circuit. The clinician identifies the thrombus location and, crucially, the "lesion of origin"—the underlying stenosis that caused the sluggish flow leading to thrombosis.

Step 3: Thrombectomy

Using the chosen mechanical device, the thrombus is macerated and aspirated. In AVGs, the thrombus is typically organized and requires aggressive mechanical intervention. In AVFs, the thrombus is often softer, allowing for easier aspiration.

Step 4: Angioplasty of Underlying Lesion

Once the conduit is cleared, the causative stenosis is addressed. High-pressure balloons are used to dilate the lesion. If the lesion shows significant elastic recoil or is a known restenotic area, a stent graft may be deployed.

Step 5: Completion Angiogram

A final run is performed to ensure optimal flow, absence of residual thrombus, and correction of all stenotic segments.

5. Risks, Side Effects, and Contraindications

Potential Complications

• Pulmonary Embolism (PE): The most feared complication. Dislodged clot fragments can migrate to the pulmonary circulation.
• Vessel Rupture: Over-dilation of a stenotic segment can lead to extravasation, requiring immediate balloon tamponade or stent graft placement.
• Hematoma: Localized bleeding at the access site.
• Infection: Introduction of bacteria into the bloodstream, especially in patients with colonized access sites.

Contraindications

• Sepsis/Bacteremia: Active infection of the access site is an absolute contraindication.
• Severe Coagulopathy: Uncorrected bleeding diathesis.
• Extensive Clot Burden: If the thrombus extends into the central veins (e.g., superior vena cava), surgical consultation is mandatory.

6. Post-Op Recovery Protocol

• Hemostasis: Manual pressure is applied to the access site for 15–20 minutes.
• Monitoring: Vital signs are checked every 15 minutes for one hour.
• Dialysis Timing: The patient can typically resume dialysis immediately or the following day, provided there is no significant residual hematoma.
• Education: Patients are instructed to monitor the thrill daily and report any changes in the access feel or sound immediately.

7. Alternative Treatments

1. Surgical Thrombectomy: Often involves an incision and physical "fogarty" catheter extraction. Indicated when endovascular approaches are contraindicated or have failed.
2. Surgical Revision/Bypass: If the underlying lesion is too complex for angioplasty, a "jump graft" or surgical re-anastomosis may be necessary.
3. Catheter Placement: If salvage is impossible, a temporary tunneled dialysis catheter is placed to maintain dialysis while a new access is planned.

8. Frequently Asked Questions (FAQ)

1. How long does the declotting procedure usually take?
The procedure typically takes 60 to 90 minutes, depending on the complexity of the thrombus and the severity of the underlying stenosis.

2. Is the procedure painful?
Local anesthesia is used at the entry site. Most patients report minimal discomfort, primarily pressure during balloon dilation.

3. What is the success rate of declotting?
Technical success (restoration of flow) is generally >90%. Primary patency (time until the next clotting event) depends heavily on the underlying anatomy.

4. Can I go back to work the same day?
It is generally recommended to avoid heavy lifting or strenuous activity with the affected arm for 24 hours to prevent hematoma formation.

5. Why did my graft clot in the first place?
The most common cause is venous outflow stenosis. As the vein narrows, blood flow slows down, creating a stagnant environment where clots can form.

6. Is there a limit to how many times a graft can be declotted?
There is no strict limit, but if a graft clots repeatedly within a short window (e.g., every 1–2 months), it is usually time to consider a surgical revision or a new access placement.

7. What is the risk of a blood clot moving to my lungs?
While pulmonary embolism is a known risk, it is rare with modern mechanical thrombectomy devices, which are designed to capture or macerate the clot safely.

8. Do I need to be on blood thinners after the procedure?
Not necessarily. Antiplatelet therapy (like Aspirin or Clopidogrel) is often prescribed, but systemic anticoagulation is usually reserved for patients with specific underlying clotting disorders.

9. How do I know if the declotting was successful?
The presence of a strong, palpable thrill (vibration) and an audible bruit (whooshing sound) at the access site is the best indicator of success.

10. What happens if the endovascular salvage fails?
If the interventionalist cannot restore flow, a vascular surgeon is consulted immediately to evaluate the patient for surgical thrombectomy or the creation of a new access point.

9. Conclusion

Endovascular salvage of thrombosed AVF/AVG is a sophisticated, life-saving intervention. By combining advanced imaging with mechanical disruption and angioplasty, clinicians can preserve precious vascular access for dialysis patients. Success relies on a multidisciplinary approach involving nephrologists, interventional radiologists, and vascular surgeons. Through diligent surveillance and timely intervention, the clinical goal of maintaining long-term, functional dialysis access remains achievable for the vast majority of patients.